{'fraction_non_alphanumeric': 0.027064538514920196, 'fraction_numerical': 0.021512838306731435, 'mean_word_length': 5.966183574879227, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
miR‐21‐3p regulates AGE/RAGE signalling and improves diabetic atherosclerosis

To explore the effects of miR‐21‐3p on diabetic atherosclerosis. Using enzyme‐linked immunosorbent assay (ELISA), we also detected the levels of soluble receptor for advanced glycation endproducts RAGE (sRAGE) in the cellular supernatant of vascular endothelial cells after transfecting them with adenovirus vector having miR‐21‐3p mimic or inhibitor. We found decrease in the expression levels of miR‐21‐3p in vascular endothelial cells (VECs) induced by high‐concentration glucose. We also observed that the introduction of miR‐21‐3p mimic significantly increased the expression of ADAM10 in the VECs. Similarly, significantly higher levels of sRAGE were found in the cultured supernatant after administration of miR‐21‐3p mimic in human vein endothelial cells. The production of reactive oxygen species and expression of inflammatory cytokines in VECs induced by LPS and high‐concentration glucose were significantly decreased after administration of miR‐21‐3p. in vivo studies revealed that intravenous injection of miR‐21‐3p at regular intervals would reduce the area of atherosclerotic lesion and elevate the serum levels of sRAGE in atherosclerotic diabetic mice. miR‐21‐3p may be beneficial in diabetic atherosclerosis by promoting the cleaved form of sRAGE and inhibition of RAGE/NADPH oxidase signalling depending on the increased expression of ADAM10.